Prediction of Breast Cancer Risk by Aberrant Methylation in Mammary Duct Lavage

2004 ◽  
Author(s):  
David M. Euhus ◽  
Sara Milchgrub ◽  
Raheela Ashfraq

2013 ◽  
Vol 49 (1) ◽  
pp. 65-71 ◽  
Author(s):  
Dominique Twelves ◽  
Ashutosh Nerurkar ◽  
Peter Osin ◽  
Ann Ward ◽  
Clare M. Isacke ◽  
...  


2007 ◽  
Vol 16 (9) ◽  
pp. 1812-1821 ◽  
Author(s):  
David M. Euhus ◽  
Dawei Bu ◽  
Raheela Ashfaq ◽  
Xian-Jin Xie ◽  
Aihua Bian ◽  
...  


Ob Gyn News ◽  
2007 ◽  
Vol 42 (19) ◽  
pp. 1-4
Author(s):  
ELIZABETH MECHCATIE


2006 ◽  
Vol 37 (12) ◽  
pp. 38
Author(s):  
HEIDI SPLETE


2005 ◽  
Vol 38 (20) ◽  
pp. 48
Author(s):  
DOUG BRUNK


2012 ◽  
Vol 45 (7) ◽  
pp. 13
Author(s):  
DIANA MAHONEY


2011 ◽  
Vol 44 (12) ◽  
pp. 60
Author(s):  
MICHELE G. SULLIVAN


Swiss Surgery ◽  
2002 ◽  
Vol 8 (2) ◽  
pp. 45-52 ◽  
Author(s):  
Remmel ◽  
Harder

Prophylactic mastectomy is an aggressive strategy for breast cancer risk reduction. The indications and efficiency of this procedures are not yet clearly defined. Randomized, prospective studies, comparing different surgical procedures with other modalities of breast cancer risk reduction are lacking. The report evaluates the existing controversy, based on Medline search in the following sequence: risk factors, possibilities of risk reduction, effectiveness of risk reduction, technical considerations and recommendations. Patient selection is difficult and needs an interdisciplinary approach. The women have to be well informed about all treatment alternatives and various reconstructive procedures. An appropriate risk reduction strategy should be selected individually for each patient. Up to now, there exist only recommendations from different institutions but no definitive guidelines.



Sign in / Sign up

Export Citation Format

Share Document